SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-035610
Filing Date
2020-03-19
Accepted
2020-03-19 08:13:28
Documents
13
Period of Report
2020-03-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2012761-1_8k.htm   iXBRL 8-K 33404
2 EXHIBIT 10.1 tm2012761d1_ex10-1.htm EX-10.1 523710
  Complete submission text file 0001104659-20-035610.txt   848576

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vygr-20200316.xsd EX-101.SCH 3219
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vygr-20200316_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vygr-20200316_pre.xml EX-101.PRE 22732
11 EXTRACTED XBRL INSTANCE DOCUMENT tm2012761-1_8k_htm.xml XML 3598
Mailing Address 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 75 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37625 | Film No.: 20726453
SIC: 2836 Biological Products, (No Diagnostic Substances)